| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 45.0703 | 27 |
| GSM780708 | Untreated after 4 days (C2_1) | 45.0539 | 27 |
| GSM780709 | Untreated after 4 days (C3_1) | 44.2548 | 23 |
| GSM780719 | Untreated after 4 days (C1_2) | 44.3785 | 24 |
| GSM780720 | Untreated after 4 days (C2_2) | 48.7013 | 44 |
| GSM780721 | Untreated after 4 days (C3_2) | 48.4722 | 43 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 45.4645 | 29 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 50.3172 | 49 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 42.3543 | 15 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 45.8059 | 31 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 43.2727 | 19 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 50.8848 | 51 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 45.0501 | 27 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 48.9696 | 45 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 49.6786 | 47 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 46.9912 | 37 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 44.59 | 25 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 51.9101 | 54 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 37.7165 | 2 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 43.4421 | 19 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 47.5845 | 39 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 46.7336 | 36 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 44.4983 | 25 |